Perriman Damien Alan has filed 3 insider transactions across 1 company since April 2026.
Most recent transaction: a grant/award of 8887 shares of EXOZYMES INC. ($EXOZ) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | EXOZYMES INC. | $EXOZ | Perriman Damien Alan | Chief Commercial Officer | A | COMMON STOCK | 8887 | $8.44 | 0.0000 | 8,387,250 | 0.00% | 0.11% |
| April 1, 2026 | EXOZYMES INC. | $EXOZ | Perriman Damien Alan | Chief Commercial Officer | A | Restricted Stock Grant for Common Stock | 62759 | $0.00 | 62,759.0000 | 8,387,250 | 9999.99% | 0.75% |
| April 1, 2026 | EXOZYMES INC. | $EXOZ | Perriman Damien Alan | Chief Commercial Officer | A | Stock Option for Common Stock | 146437 | $0.00 | 146,437.0000 | 8,387,250 | 9999.99% | 1.75% |